JPRN-UMIN000032867已完成未知
Efficacy and safety of sucroferric oxyhydroxide on hemodialysis patients - Efficacy of sucroferric oxyhydroxide on HD
Department of Nephrology, hypertension and Endocrinology, Nihon University School of Medicine0 个研究点目标入组 60 人开始时间: 2018年6月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) age < 20 years or > 85 years; (2) history of severe heart failure, angina, myocardial infarction, or stroke within the past 6 months; (3) presence of infectious disease, malignant tumors, or treatment with steroids or immunosuppressants; (4) current hospitalization; and (5) treatment with ferric citrate hydrate within the past 6 months.
研究者
相似试验
已完成
不适用
Study of the efficacy of sucroferric oxyhydroxide (chewable tablet) on the control of CKD-MBD and improvement of renal anemia in hemodialysis patients with hyperphosphatemia.Hyperphosphatemia in chronic kidney disease patients on hemodialysisJPRN-UMIN000023657Kawashima Hospital, Social Medical Corporation Kawashima Hospital Group50
已完成
不适用
The effect of sucroferric oxyhydroxide starting from a small amountChronic renal failureJPRN-UMIN000034640Saitama Tsukinomori Clinic40
招募中
不适用
Oral administration of sucroferric oxyhydroxide during hemodialysis sessions against resistant hyperphosphatemiaResistant hyperphosphatemia in maintenance hemodialysis patientsJPRN-UMIN000031337Dialysis Center, JA Toride Medical Center20
已完成
不适用
Effect of Intravenous Saccharated Ferric Oxide on Serum FGF23 and Mineral Metabolism in Hemodialysis PatientsHemodialysis patients with iron-deficiency anemiaJPRN-UMIN000004814kobe university school of medicine, division of nephrology and kidney center30
招募中
3 期
Investigating the efficacy and safety of Hydroxychloroquine nasal spray in controlling the symptoms of patients with COVID-19IRCT20080901001165N51Sina Darou Laboratories Company80